FBTAX
Price
$24.91
Change
-$0.61 (-2.39%)
Updated
Apr 3 closing price
Net Assets
1.39B
LHCVX
Price
$18.01
Change
-$0.44 (-2.38%)
Updated
Apr 3 closing price
Net Assets
7.48M
Ad is loading...

FBTAX vs LHCVX

Header iconFBTAX vs LHCVX Comparison
Open Charts FBTAX vs LHCVXBanner chart's image
Fidelity Advisor Biotechnology A
Price$24.91
Change-$0.61 (-2.39%)
VolumeN/A
Net Assets1.39B
Lord Abbett Health Care R6
Price$18.01
Change-$0.44 (-2.38%)
VolumeN/A
Net Assets7.48M
FBTAX vs LHCVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FBTAX vs. LHCVX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTAX is a Hold and LHCVX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.39B vs. LHCVX (7.48M). FBTAX pays higher dividends than LHCVX: FBTAX (2.97) vs LHCVX (0.59). FBTAX was incepted earlier than LHCVX: FBTAX (24 years) vs LHCVX (6 years). LHCVX (3.10) is less costly to investors than FBTAX (0.96). LHCVX is a more actively managed with annual turnover of: 88.00 vs. FBTAX (73.00). FBTAX (0) and LHCVX (0) have matching initial minimum investment requirements. LHCVX annual gain was more profitable for investors over the last year : -3.24 vs. FBTAX (-12.66). LHCVX return over 5 years is better than : 32.77 vs. FBTAX (10.53).
FBTAXLHCVXFBTAX / LHCVX
Total Expense Ratio0.960.60160%
Annual Report Gross Expense Ratio0.963.1031%
Fund Existence24 years6 years-
Gain YTD-6.211-5.044123%
Front Load6%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.39B7.48M18,594%
Annual Yield % from dividends2.970.59501%
Returns for 1 year-12.66-3.24390%
Returns for 3 years2.83-0.81-349%
Returns for 5 years10.5332.7732%
Returns for 10 years-4.32N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FUNYX34.99N/A
N/A
Pioneer Fundamental Growth Y
VNSCX18.23N/A
N/A
Natixis Vaughan Nelson Select C
NRSRX47.98N/A
N/A
Neuberger Berman Sustainable Equity R6
DLACX14.01N/A
N/A
BNY Mellon Large Cap Equity Y
MIEFX13.35N/A
N/A
Matthews Emerging Markets Equity Ins